{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:37:59Z","timestamp":1794483479146,"version":"4.9.1"},"reference-count":34,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2027,5,22]],"date-time":"2027-05-22T00:00:00Z","timestamp":1810944000000},"content-version":"am","delay-in-days":233,"URL":"http:\/\/www.elsevier.com\/open-access\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-017"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-037"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-012"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-029"},{"start":{"date-parts":[[2026,10,1]],"date-time":"2026-10-01T00:00:00Z","timestamp":1790812800000},"content-version":"stm-asf","delay-in-days":0,"URL":"https:\/\/doi.org\/10.15223\/policy-004"}],"funder":[{"DOI":"10.13039\/100007261","name":"New York Academy of Medicine","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100007261","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K23DA055933"],"award-info":[{"award-number":["K23DA055933"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["K24DA057873"],"award-info":[{"award-number":["K24DA057873"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100000026","name":"National Institute on Drug Abuse","doi-asserted-by":"publisher","award":["R01DA044878"],"award-info":[{"award-number":["R01DA044878"]}],"id":[{"id":"10.13039\/100000026","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","jsatjournal.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Journal of Substance Use and Addiction Treatment"],"published-print":{"date-parts":[[2026,10]]},"DOI":"10.1016\/j.josat.2026.210027","type":"journal-article","created":{"date-parts":[[2026,5,20]],"date-time":"2026-05-20T18:07:06Z","timestamp":1779300426000},"page":"210027","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["\u201cIt was good because they have a relationship with us\u201d: A qualitative study on low-threshold buprenorphine treatment at syringe services programs"],"prefix":"10.1016","volume":"189","author":[{"given":"Emma","family":"McGill","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Benjamin T.","family":"Hayes","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-2521-6329","authenticated-orcid":false,"given":"Teresa","family":"L\u00f3pez-Castro","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Juan Gatica","family":"Portillo","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Stephanie","family":"Maricic","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Megan","family":"Ghiroli","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0002-6904-4795","authenticated-orcid":false,"given":"Aaron D.","family":"Fox","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.josat.2026.210027_bb0005","series-title":"Qualitative data: An introduction to coding and analysis","author":"Auerbach","year":"2003"},{"issue":"2","key":"10.1016\/j.josat.2026.210027_bb0010","doi-asserted-by":"crossref","first-page":"167","DOI":"10.1080\/08897077.2018.1443541","article-title":"Description and outcomes of a buprenorphine maintenance treatment program integrated within prevention point Philadelphia, an urban syringe exchange program","volume":"39","author":"Bachhuber","year":"2018","journal-title":"Substance Abuse"},{"key":"10.1016\/j.josat.2026.210027_bb0015","doi-asserted-by":"crossref","first-page":"173","DOI":"10.2147\/SAR.S475807","article-title":"Community-based medications-first for opioid use disorder: Care utilization and mortality outcomes","volume":"15","author":"Banta-Green","year":"2024","journal-title":"Substance Abuse and Rehabilitation"},{"issue":"1","key":"10.1016\/j.josat.2026.210027_bb0020","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-022-00721-6","article-title":"We want everything in a one-stop shop: Acceptability and feasibility of PrEP and buprenorphine implementation with mobile syringe services for black people who inject drugs","volume":"19","author":"Bartholomew","year":"2022","journal-title":"Harm Reduction Journal"},{"key":"10.1016\/j.josat.2026.210027_bb0025","doi-asserted-by":"crossref","DOI":"10.1016\/j.jsat.2021.108633","article-title":"I didn\u2019t feel like a number: The impact of nurse care managers on the provision of buprenorphine treatment in primary care settings","volume":"132","author":"Beharie","year":"2022","journal-title":"Journal of Substance Abuse Treatment"},{"key":"10.1016\/j.josat.2026.210027_bb0030","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugalcdep.2022.109323","article-title":"Harm reduction and health services provided by syringe services programs in 2019 and subsequent impact of COVID-19 on services in 2020","volume":"232","author":"Behrends","year":"2022","journal-title":"Drug and Alcohol Dependence"},{"issue":"7","key":"10.1016\/j.josat.2026.210027_bb0035","article-title":"Public sector low-threshold office-based buprenorphine treatment: Outcomes at year 7","volume":"12","author":"Bhatraju","year":"2017","journal-title":"Addiction Science & Clinical Practice"},{"issue":"1","key":"10.1016\/j.josat.2026.210027_bb0040","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-022-00331-4","article-title":"Patient evaluation of a smartphone application for telehealth care of opioid use disorder","volume":"17","author":"Bosse","year":"2022","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.210027_bb0045","doi-asserted-by":"crossref","first-page":"183","DOI":"10.1016\/j.drugpo.2019.01.010","article-title":"The triple wave epidemic: Supply and demand drivers of the U.S. opioid overdose crisis","volume":"71","author":"Ciccarone","year":"2019","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2026.210027_bb0050","doi-asserted-by":"crossref","DOI":"10.1007\/s11606-019-05311-0","article-title":"If it wasn\u2019t for him, I wouldn\u2019t have talked to them: Qualitative study of addiction peer mentorship in the hospital","author":"Collins","year":"2019","journal-title":"Journal of General Internal Medicine"},{"issue":"7","key":"10.1016\/j.josat.2026.210027_bb0055","first-page":"500","article-title":"Buprenorphine treatment in an urban community health center: What to expect","volume":"40","author":"Cunningham","year":"2008","journal-title":"Family Medicine"},{"issue":"2","key":"10.1016\/j.josat.2026.210027_bb0060","first-page":"31","article-title":"Buprenorphine maintenance for opioid dependence in public sector healthcare: Benefits and barriers","volume":"1","author":"Duncan","year":"2015","journal-title":"Journal of Addiction Medicine and Therapeutic Science"},{"issue":"2","key":"10.1016\/j.josat.2026.210027_bb0065","doi-asserted-by":"crossref","first-page":"155","DOI":"10.1080\/08897077.2015.1011820","article-title":"Harm reduction agencies as a potential site for buprenorphine treatment","volume":"36","author":"Fox","year":"2015","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2026.210027_bb0070","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1080\/08897077.2015.1088496","article-title":"Optimizing psychosocial support during office-based buprenorphine treatment in primary care: Patients\u2019 experiences and preferences","volume":"37","author":"Fox","year":"2016","journal-title":"Substance Abuse"},{"issue":"4","key":"10.1016\/j.josat.2026.210027_bb0075","doi-asserted-by":"crossref","first-page":"983","DOI":"10.1080\/08897077.2021.1901173","article-title":"We\u2019ll be able to take care of ourselves: A qualitative study of client attitudes toward implementing buprenorphine treatment at syringe services programs","volume":"42","author":"Frost","year":"2021","journal-title":"Substance Abuse"},{"issue":"6","key":"10.1016\/j.josat.2026.210027_bb0080","first-page":"1273","article-title":"The behavioral model for vulnerable populations: Application to medical care use and outcomes for homeless people","volume":"34","author":"Gelberg","year":"2000","journal-title":"Health Services Research"},{"issue":"4","key":"10.1016\/j.josat.2026.210027_bb0085","doi-asserted-by":"crossref","first-page":"511","DOI":"10.1016\/j.jsat.2013.11.002","article-title":"Mobile opioid agonist treatment and public funding expands treatment for disenfranchised opioid-dependent individuals","volume":"46","author":"Hall","year":"2014","journal-title":"Journal of Substance Abuse Treatment"},{"issue":"8","key":"10.1016\/j.josat.2026.210027_bb0090","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1080\/10826084.2021.1908360","article-title":"The doctor says you cannot have buprenorphine: Autonomy and use of prescribed or non-prescribed buprenorphine","volume":"56","author":"Hayes","year":"2021","journal-title":"Substance Use & Misuse"},{"issue":"3","key":"10.1016\/j.josat.2026.210027_bb0095","doi-asserted-by":"crossref","first-page":"356","DOI":"10.1080\/08897077.2019.1635557","article-title":"Engaging an unstably housed population with low-barrier buprenorphine treatment at a syringe services program","volume":"41","author":"Hood","year":"2020","journal-title":"Substance Abuse"},{"issue":"1","key":"10.1016\/j.josat.2026.210027_bb0100","doi-asserted-by":"crossref","DOI":"10.1186\/s13722-023-00394-x","article-title":"Three decades of research in substance use disorder treatment for syringe services program participants: A scoping review","volume":"18","author":"Jakubowski","year":"2023","journal-title":"Addiction Science & Clinical Practice"},{"key":"10.1016\/j.josat.2026.210027_bb0105","article-title":"Defining low-threshold buprenorphine treatment","author":"Jakubowski","year":"2019","journal-title":"Journal of Addiction Medicine"},{"issue":"1","key":"10.1016\/j.josat.2026.210027_bb0110","doi-asserted-by":"crossref","DOI":"10.1186\/s12954-022-00654-0","article-title":"Implementation of buprenorphine services in NYC syringe services programs: A qualitative process evaluation","volume":"19","author":"Jakubowski","year":"2022","journal-title":"Harm Reduction Journal"},{"issue":"8","key":"10.1016\/j.josat.2026.210027_bb0115","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2023.27488","article-title":"Use of medication for opioid use disorder among adults with past-year opioid use disorder in the U.S., 2021","volume":"6","author":"Jones","year":"2023","journal-title":"JAMA Network Open"},{"key":"10.1016\/j.josat.2026.210027_bb0120","doi-asserted-by":"crossref","DOI":"10.1016\/j.drugpo.2022.103786","article-title":"Has the treatment gap for opioid use disorder narrowed in the U.S.? A yearly assessment from 2010 to 2019","volume":"110","author":"Krawczyk","year":"2022","journal-title":"International Journal of Drug Policy"},{"key":"10.1016\/j.josat.2026.210027_bb0125","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.drugalcdep.2015.03.002","article-title":"Peering into the literature: A systematic review of the roles of people who inject drugs in harm reduction initiatives","volume":"151","author":"Marshall","year":"2015","journal-title":"Drug and Alcohol Dependence"},{"issue":"2","key":"10.1016\/j.josat.2026.210027_bb0130","doi-asserted-by":"crossref","DOI":"10.1002\/14651858.CD002207.pub4","article-title":"Buprenorphine maintenance versus placebo or methadone maintenance for opioid dependence","volume":"2014","author":"Mattick","year":"2014","journal-title":"Cochrane Database of Systematic Reviews"},{"key":"10.1016\/j.josat.2026.210027_bb0135","author":"North American Syringe Exchange Network"},{"issue":"3","key":"10.1016\/j.josat.2026.210027_bb0140","doi-asserted-by":"crossref","first-page":"391","DOI":"10.1080\/00952990.2024.2332597","article-title":"Attitudes toward medications for opioid use disorder among peer recovery specialists","volume":"50","author":"Pasman","year":"2024","journal-title":"The American Journal of Drug and Alcohol Abuse"},{"key":"10.1016\/j.josat.2026.210027_bb0145","doi-asserted-by":"crossref","DOI":"10.1016\/j.josat.2023.209121","article-title":"Ambivalence and contingencies: A qualitative examination of peer recovery coaches\u2019 attitudes toward medications for opioid use disorder","volume":"155","author":"Pasman","year":"2023","journal-title":"Journal of Substance Use and Addiction Treatment"},{"key":"10.1016\/j.josat.2026.210027_bb0150","article-title":"Low-threshold buprenorphine in non-traditional settings: A scoping review","author":"Patterson","year":"2025","journal-title":"Substance Use: Research and Treatment"},{"key":"10.1016\/j.josat.2026.210027_bb0155","doi-asserted-by":"crossref","DOI":"10.1016\/j.cct.2021.106674","article-title":"Onsite buprenorphine inductions at harm reduction agencies to increase treatment engagement and reduce HIV risk: Design and rationale","volume":"114","author":"Perez-Correa","year":"2022","journal-title":"Contemporary Clinical Trials"},{"issue":"3","key":"10.1016\/j.josat.2026.210027_bb0160","doi-asserted-by":"crossref","first-page":"278","DOI":"10.1080\/10550887.2012.694603","article-title":"Opioid maintenance treatment as a harm reduction tool for opioid-dependent individuals in new York City","volume":"31","author":"Stancliff","year":"2012","journal-title":"Journal of Addictive Diseases"},{"issue":"1","key":"10.1016\/j.josat.2026.210027_bb0165","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1080\/07853890.2023.2182908","article-title":"Adaptation of the tele-harm reduction intervention to promote initiation and retention in buprenorphine treatment","volume":"55","author":"Suarez","year":"2023","journal-title":"Annals of Medicine"},{"issue":"6","key":"10.1016\/j.josat.2026.210027_bb0170","doi-asserted-by":"crossref","first-page":"632","DOI":"10.1097\/ADM.0000000000001202","article-title":"ASAM clinical considerations: Buprenorphine treatment of opioid use disorder for individuals using high-potency synthetic opioids","volume":"17","author":"Weimer","year":"2023","journal-title":"Journal of Addiction Medicine"}],"container-title":["Journal of Substance Use and Addiction Treatment"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001475?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2949875926001475?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,12]],"date-time":"2026-11-12T11:10:09Z","timestamp":1794481809000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2949875926001475"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,10]]},"references-count":34,"alternative-id":["S2949875926001475"],"URL":"https:\/\/doi.org\/10.1016\/j.josat.2026.210027","relation":{},"ISSN":["2949-8759"],"issn-type":[{"value":"2949-8759","type":"print"}],"subject":[],"published":{"date-parts":[[2026,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"\u201cIt was good because they have a relationship with us\u201d: A qualitative study on low-threshold buprenorphine treatment at syringe services programs","name":"articletitle","label":"Article Title"},{"value":"Journal of Substance Use and Addiction Treatment","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.josat.2026.210027","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 Elsevier Inc. All rights are reserved, including those for text and data mining, AI training, and similar technologies.","name":"copyright","label":"Copyright"}],"article-number":"210027"}}